HNF1A-MODY变体的功能分析优化已识别序列变异的解读
研究对来自20个捷克糖尿病家系48例个体的17个HNF1A变体进行生物信息学与功能蛋白分析(转录激活、蛋白表达、DNA结合、核定位),12个变体转录活性或DNA结合显著降低(<40%)被判为(可能)致病,功能分析使10/17(59%)变体重新分类,20/29(69%)致病性变体携带者糖尿病治疗改善。
要点
- 17个HNF1A变体中12个转录活性或DNA结合显著降低(<40%),判为(可能)致病。
- 功能分析使10/17(59%)变体重新分类,2个为(可能)良性、3个意义不明。
- 20/29(69%)的(可能)致病HNF1A变体携带者糖尿病治疗得到改善。
核心结论
- 对HNF1A变体进行功能评估有助于更好预测致病效应、改善诊断解读和治疗,尤其在共分离或家族史数据不可用或表型多样与其他类型糖尿病重叠时。
研究设计与样本
- 研究纳入来自20个捷克糖尿病家系的48例个体(33例女性/15例男性)中识别的17个HNF1A变体,采用生物信息学工具和功能蛋白分析(转录激活、蛋白表达、DNA结合和核定位)。
主要发现
- 17个变体中12个(p.Lys120Glu、p.Gln130Glu、p.Arg131Pro、p.Leu139Pro、p.Met154Ile、p.Gln170Ter、p.Glu187SerfsTer40、p.Phe215SerfsTer18、p.Gly253Arg、p.Leu383ArgfsTer3、p.Gly437Val和p.Thr563HisfsTer85)转录活性或DNA结合显著降低(<40%),被判为(可能)致病。
- 17个变体中2个为(可能)良性,3个仍为意义不明。
- 功能分析使10/17(59%)变体得以重新分类。
- 20/29(69%)的(可能)致病HNF1A变体携带者糖尿病治疗得到改善。
临床怎么用
- 作者认为功能评估HNF1A变体是必要的,以更好预测致病效应并改善诊断解读和治疗,尤其在共分离或家族史数据不可用或表型多样与其他类型糖尿病重叠时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: While rare variants of the hepatocyte nuclear factor-1 alpha (HNF1A) gene can cause maturity-onset diabetes of the young (HNF1A-MODY), other variants can be risk factors for the development of type 2 diabetes. As has been suggested by the American College of Medical Genetics (ACMG) guidelines for variant interpretation, functional studies provide strong evidence to classify a variant as pathogenic. OBJECTIVE: We hypothesized that a functional evaluation can improve the interpretation of the HNF1A variants in our Czech MODY Registry. DESIGN, SETTINGS, AND PARTICIPANTS: We studied 17 HNF1A variants that were identified in 48 individuals (33 female/15 male) from 20 Czech families with diabetes, using bioinformatics in silico tools and functional protein analyses (transactivation, protein expression, DNA binding, and nuclear localization). RESULTS: Of the 17 variants, 12 variants (p.Lys120Glu, p.Gln130Glu, p.Arg131Pro, p.Leu139Pro, p.Met154Ile, p.Gln170Ter, p.Glu187SerfsTer40, p.Phe215SerfsTer18, p.Gly253Arg, p.Leu383ArgfsTer3, p.Gly437Val, and p.Thr563HisfsTer85) exhibited significantly reduced transcriptional activity or DNA binding (< 40%) and were classified as (likely) pathogenic, 2/17 variants were (likely) benign and 3/17 remained of uncertain significance. Functional analyses allowed for the reclassification of 10/17 variants (59%). Diabetes treatment was improved in 20/29 (69%) carriers of (likely) pathogenic HNF1A variants. CONCLUSION: Functional evaluation of the HNF1A variants is necessary to better predict the pathogenic effects and to improve the diagnostic interpretation and treatment, particularly in cases where the cosegregation or family history data are not available or where the phenotype is more diverse and overlaps with other types of diabetes.
引用
- Malikova J, Kaci A, Dusatkova P, et al. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants. J Clin Endocrinol Metab. 2020. PMID: 32017842. doi:10.1210/clinem/dgaa051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。